Remove Allergies Remove Engineer Remove Protein
article thumbnail

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Scienmag

Computer design of synthetic proteins is creating potent, stable antivirals that block infection at least as well as monoclonal antibodies Credit: Ian Haydon/UW Medicine Institute for Protein Design Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.

Protein 40
article thumbnail

FDA Issues Two Guidance Documents on Food Allergen Labeling Requirements

FDA Law Blog

labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. 1, 2023, sesame.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Membranes unlock potential to vastly increase cell-free vaccine production

Scienmag

In February, the researchers introduced […].

article thumbnail

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Roots Analysis

It is important in the process of protein synthesis because mRNA is responsible for transferring genetic information from DNA to ribosomes, which then decodes the genetic information into a protein. Messenger ribonucleic acid (mRNA) is a single-stranded molecule that is complementary to a gene’s DNA.

article thumbnail

Precision Fermentation Study May Revolutionize Food Quality and Sustainability

XTalks

The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens. The study proposes a new system for categorizing genetically engineered products to improve public perception and acceptance.

article thumbnail

HIV Vaccine Trial of Vir Biotech’s New Candidate VIR-1388 Begins

XTalks

This groundbreaking endeavor has received support from the National Institute of Allergy and Infectious Diseases (NIAID). These T cells are engineered to recognize various HIV proteins in a unique manner compared to previous experimental HIV vaccines. mRNA, 2) BG505 MD39.3 gp151 mRNA and 3) BG505 MD39.3 gp151 CD4KO mRNA.

article thumbnail

World AIDS Day 2023: New and Promising Treatments for HIV/AIDS

XTalks

Its mechanism of action involves blocking the protein shell (capsid) of the HIV-1 virus, disrupting multiple crucial stages of the viral lifecycle. Developed by Gilead, Sunlenca is the first drug in a novel class known as capsid inhibitors to receive FDA approval for treating HIV-1. In addition, Vir Biotechnology, Inc.